“Exploring Chalcone Derivatives as GABA Receptor Agents for Neurological Disorder Treatment: The Role of Structure-Activity Relationship and In Silico Tools”

https://pubmed.ncbi.nlm.nih.gov/38112471

This review discusses the potential of chalcone derivatives as GABA receptor agents for treating neurological disorders, such as epilepsy and anxiety, highlighting the importance of structure-activity relationship and in silico tools in developing GABA agonists.